Bulletin from the Annual General Meeting of ContextVision AB (publ) on 14 May 2024

ContextVision, Digital Pathology, Home, Investor News, News 2024-05-14
Adoption of the accounts The Annual General Meeting approved the Company’s income statement and balance sheet for 2023. The Board members and the Managing Director were discharged from liability for the fiscal year 2023. Disposition of profits The Annual General Meeting resolved, in accordance with the Board’s proposal, that this year’s results shall be carried […]
Read More

Notice to Attend the Annual General Meeting in ContextVision AB (publ)

ContextVision, Digital Pathology, Home, Investor News, News 2024-04-12
Notification etc Shareholders who wish to participate in the annual general meeting with the right to vote shall be recorded as shareholder in the share register kept by Euroclear Sweden AB on May 3, 2024, temporary registration for shareholders registered at Norska Verdipapirsentralen (VPS) is made by DNB Bank ASA, see below; and give notice […]
Read More

ContextVision – Invitation to Annual General Meeting 2023

ContextVision, Digital Pathology, Home, Investor News, News 2023-03-30
STOCKHOLM – March 30, 2023 – ContextVision hereby invites shareholders to the Annual General Meeting on May 3, 2023. Please find attached the invitation including agenda and details on how to register and vote. Please contact:  for any questions regarding the AGM. For inquiries, please contact CFO Markus Hökerberg E-mail:
Read More

ContextVision – Invitation to Annual General Meeting 2022

ContextVision, Digital Pathology, Home, Investor News, News 2022-03-31
STOCKHOLM – March 31, 2022 – ContextVision hereby invites shareholders to the Annual General Meeting on May 4, 2022. Please find attached the invitation including agenda and details on how to register and vote. Please contact: for any questions regarding the AGM. For inquiries, please contact CFO Markus Hökerberg E-mail:
Read More

ContextVision presents Annual Report 2021

Annual reports, ContextVision, Digital Pathology, Home, Investor News, News 2022-03-31
STOCKHOLM – March 31, 2022 – Please find ContextVision’s Annual Report 2021 attached. The report can also be found on the company’s website: www.contextvision.se Printed copies of the report will be distributed upon request by e-mail: For inquiries, please contact CFO Markus Hökerberg E-mail: ### About ContextVision ContextVision is a medical technology software company […]
Read More

ContextVision – Information regarding dividend and reverse share split in Inify Laboratories

ContextVision, Digital Pathology, Home, Investor News, News 2022-02-11
ContextVision AB (“ContextVision” or the “Company”) will, in accordance with the press release published on 2 February 2022, distribute all shares in its wholly-owned subsidiary INIFY Laboratories AB (“INIFY”) to the shareholders of ContextVision. The shares in INIFY are expected to be delivered to shareholders who have their shares registered at Euroclear Sweden AB around […]
Read More

ContextVision announces resolution regarding record date for dividend

ContextVision, Digital Pathology, Home, Investor News, News 2022-02-02
Stockholm, February 2nd, at the extraordinary general meeting in ContextVision AB (“ContextVision” or the “Company”) held on 10 December 2021 the meeting resolved to distribute all shares in the wholly-owned company INIFY Laboratories AB, company registration number 559345-4431 (“INIFY”) to the shareholders of the Company. The board of directors has determined the record date for […]
Read More

In the Pan-European multicenter clinical study FirstPath, INIFY Prostate produced highly accurate, robust and homogenous results at all sites

ContextVision, Digital Pathology, Export, Home, Investor News, News, Patologi 2021-08-31
STOCKHOLM – August 31, 2021 – ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today announced that results from FirstPath – a European multicenter clinical study evaluating performance of INIFY® Prostate in routine clinical practice – were presented at the European Congress of Pathology by […]
Read More